Literature DB >> 18637136

Molecular diagnosis of leishmaniosis in the Paraná state of southern Brazil.

Elisângela de Fátima Arruda Pereira1, Vanete Thomaz-Soccol, Hermênio Cavalcante Lima, Andréa Thomaz-Soccol, Edilene Alcântara de Castro, Fabiane Mulinari-Brenner, Flávio Queiroz-Telles, Ennio Luz.   

Abstract

The objective of the present study was to establish a polymerase chain reaction (PCR) technique for the diagnosis of cutaneous and mucocutaneous leishmaniosis from autochthonous cases in the state of Paraná in southern Brazil as well as imported cases. We sought to determine its utility and accuracy compared with smears and present culture methods. To standardize PCR samples, skin and mucosal punch biopsies from human lesions were performed on patients living in different regions of the Paraná state (76 cases) and other endemic areas of Brazil and Argentina (7 cases). For PCR standardization, two pairs of primers (MP1L/MP3H and B1/B2) were utilized for amplification of the conserved sequences in the minicircle of kinetoplast DNA (kDNA) for the Leishmania braziliensis complex. Two other primer pairs (b1/b2 and a1/a2) were species-specific for L. (V.) braziliensis and L. (V.) amazonensis, respectively. After differential diagnosis, eight patients had clinical diagnosis of the cutaneous ulcer changed to others pathologies such as syphilis, baso-cellular carcinoma, varicose ulcer, ecthyma and paracoccidioidomycosis. Of the 75 patients with cutaneous (CL) and mucocutaneous (MCL) lesions who provided samples, 47 (46 CL + 1 MCL) were diagnosed with leishmaniosis by smear and 57 (52 LC + 5 MCL) were diagnosed by culture methods. In contrast, our PCR technique presented higher accuracy when compared to the direct examination and culture of parasites. PCR is applicable both for CL where all 61 lesions were diagnosed, and MCL where 12 of 14 lesions were diagnosed. This molecular biology technique is also a faster and more specific diagnostic method compared with present parasitological procedures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18637136     DOI: 10.1111/j.1600-0625.2008.00744.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  6 in total

Review 1.  Accuracy of mucocutaneous leishmaniasis diagnosis using polymerase chain reaction: systematic literature review and meta-analysis.

Authors:  Ciro Martins Gomes; Suleimy Cristina Mazin; Elisa Raphael dos Santos; Mariana Vicente Cesetti; Guilherme Albergaria Brízida Bächtold; João Henrique de Freitas Cordeiro; Fabrício Claudino Estrela Terra Theodoro; Fabiana dos Santos Damasco; Sebastián Andrés Vernal Carranza; Adriana de Oliveira Santos; Ana Maria Roselino; Raimunda Nonata Ribeiro Sampaio
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-03-31       Impact factor: 2.743

Review 2.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

3.  Noninvasive molecular diagnosis of human visceral leishmaniasis.

Authors:  Manisha Vaish; Sanjana Mehrotra; Jaya Chakravarty; Shyam Sundar
Journal:  J Clin Microbiol       Date:  2011-03-09       Impact factor: 5.948

4.  IL-1 signalling is dispensable for protective immunity in Leishmania-resistant mice.

Authors:  Kordula Kautz-Neu; Susanna L Kostka; Stephanie Dinges; Yoichiro Iwakura; Mark C Udey; Esther von Stebut
Journal:  Exp Dermatol       Date:  2010-10-18       Impact factor: 3.960

5.  Ixodid fauna and zoonotic agents in ticks from dogs: first report of Rickettsia rickettsii in Rhipicephalus sanguineus in the state of Mato Grosso do Sul, mid-western Brazil.

Authors:  Robson Ferreira Cavalcante de Almeida; Marcos Valério Garcia; Rodrigo Casquero Cunha; Jaqueline Matias; Elaine Araújo e Silva; Maria de Fatima Cepa Matos; Renato Andreotti
Journal:  Exp Appl Acarol       Date:  2012-12-11       Impact factor: 2.132

6.  Cost-effectiveness analysis of Mucosal Leishmaniasis diagnosis with PCR-based vs parasitological tests in Colombia.

Authors:  Liliana Castillo-Rodríguez; Clemencia Ovalle-Bracho; Diana Díaz-Jiménez; Guillermo Sánchez-Vanegas; Sandra Muvdi-Arenas; Carlos Castañeda-Orjuela
Journal:  PLoS One       Date:  2019-11-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.